When Mysm1 was knocked down in AD-MSCs, their immunosuppressive capacity was significantly reduced, as evidenced by the diminished inhibition of T cell proliferation, increased pro-inflammatory factor secretion, and decreased nitric oxide (NO) production in vitro [45]. Here, MYSM1 is linked to Alzheimer disease.